PS

Payal Singh

Active Director Director DIN 08807232
DIN 08807232 First appointment Jul 2020 Primary industry Electrnoics
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value •••• Premium profile

About Payal Singh

Data last updated:

Payal Singh is a Director at Minslear Biotech Private Limited (since 2020). The company operates in Electrnoics. Minslear Biotech Private Limited reported revenue of ₹3.2 Lakh (FY 2024).

DIN 08807232
Primary Designation Director
Industry Electrnoics
First Appointment 24 Jul 2020
Oldest Company Age 6 yrs
Largest company Minslear Biotech Private Limited · ₹3.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Minslear Biotech Private Limited U52603RJ2020PTC069828
Director24 Jul 20202020₹3.2 Lakh (FY 2024)Active

Board colleagues of Payal Singh

NameDINCompanyDesignation
Radha Singh09844495Minslear Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Minslear Biotech Private Limited
Premium access

Shareholding and investment profile for Payal Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Payal Singh

Payal Singh currently holds 1 directorship: Minslear Biotech Private Limited (Director, since 24 Jul 2020, revenue ₹3.2 Lakh (FY 2024)).

Payal Singh was first appointed on 24 Jul 2020 as Director at Minslear Biotech Private Limited.

The current boards of Payal Singh's companies include Radha Singh (Minslear Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available